Clinical Trial Update: Neutrophil FFA2/GPR43 Receptor Expression in Patients With the Diagnosis of Sepsis

View source ↗

Summary

A clinical trial investigating neutrophil FFA2/GPR43 receptor expression in sepsis patients has been withdrawn. The study included conditions such as septic sho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intra-abdominal Sepsis
• Multiple Organ Dysfunction Syndrome
• Sepsis
• Septic Shock

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Sepsis, Septic Shock | Status: WITHDRAWN